REGULATORY
Hyperthyroidism Added to Serious ADR Section of Flolan’s Package Insert
In Pharmaceuticals and Medical Devices Safety Information No. 286 released on December 27, the Ministry of Health, Labor and Welfare (MHLW; Korosho) announced the revision of the precautions section of the package insert for GlaxoSmithKline’s (GSK) pulmonary hypertension treatment Flolan…
To read the full story
REGULATORY
- PM Takaichi Keeps Cabinet Intact after Lower House Vote
February 18, 2026
- LDP Returnees Set Sights on Social Security, Drug Policy as Special Diet Opens
February 18, 2026
- 10 Firms Win Approval for Bilanoa Generics, 2 Contenders for Fycompa
February 17, 2026
- MHLW to Brand OTC-Like Drug Cost Rule as “Partially Non-Insured Care”
February 17, 2026
- Taiyo Pharma’s Propranolol Designated as Drug for Specific Use
February 17, 2026
The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…





